0.00Open0.00Pre Close0 Volume0 Open Interest67.00Strike Price0.00Turnover448.71%IV-16.40%PremiumDec 27, 2024Expiry Date13.14Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9685Delta0.0091Gamma6.14Leverage Ratio-1.5162Theta0.0003Rho5.95Eff Leverage0.0012Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet